Ando Y, Fuse E, Figg WD (1. 6. 2002). „Thalidomide metabolism by the CYP2C subfamily”. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8 (6): 1964—73. PMID12060642. Приступљено 18. 6. 2009.
Rao, KV (2007). „Lenalidomide in the treatment of multiple myeloma”. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 64 (17): 1799—807. PMID17724360. doi:10.2146/ajhp070029.
Ando Y, Fuse E, Figg WD (1. 6. 2002). „Thalidomide metabolism by the CYP2C subfamily”. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 8 (6): 1964—73. PMID12060642. Приступљено 18. 6. 2009.
Rao, KV (2007). „Lenalidomide in the treatment of multiple myeloma”. American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists. 64 (17): 1799—807. PMID17724360. doi:10.2146/ajhp070029.
Foggo, Daniel (8. 2. 2009). „Thalidomide 'was created by the Nazis”. London: The Times. Архивирано из [ttp://www.timesonline.co.uk/tol/life_and_style/health/article5683577.ece оригинала] 29. 04. 2011. г. Приступљено 28. 03. 2010.
Moghe, Vijay V; et al. (2008). „Thalidomide”(PDF). Bombay Hospital Journal. Bombay: Bombay Hospital. 50 (3): 446—. Архивирано из оригинала(PDF) 22. 07. 2011. г. Приступљено 25. 10. 2009.